Pcp45 - The Role of Crossover and Treatment Switching in Indirect Treatment Comparson in Immuno-Oncology

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.520
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Role of Radiation Oncology in Immuno‐Oncology

Oncologist
Cancer ResearchMedicineOncology
2019English

Mevalonate Metabolism in Immuno-Oncology

Frontiers in Immunology
AllergyImmunology
2017English

Adjusting for Treatment Switching in Oncology Trials: A Systematic Review and Recommendations for Reporting

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2020English

The Role of Interventional Oncology in the Treatment of Colorectal Cancer Liver Metastases

Annals of Gastroenterology
2019English

Immuno‐Oncology Forum

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Immuno-Oncology and Immunotherapy

2012English

Pcn318 - Conducting and Reporting Indirect Treatment Comparisons: A Critical Appraisal of Oncology Technology Appraisals

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Developing Best Practices for Managing Treatment Switching in the Design, Conduct, Analysis, and Reporting of Oncology Drug Clinical Trials

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Immuno‐oncology for Surgeons

British Journal of Surgery
Surgery
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy